What is Ventas, Inc.'s earnings per share (EPS)?

Ventas, Inc. (VTR) reported diluted earnings per share of $0.54 for fiscal year 2025. This represents a 184.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ventas, Inc. (VTR) Financials

VTR

FY2025 annual

Revenue $5.8B +18.5% YoY

Net Income $261.5M +196.0% YoY

EPS (Diluted) $0.54 +184.2% YoY

Free Cash Flow -$1.3B -6.8% YoY

Market Cap $42.1B as of Oct 10, 2026

Price / Sales 6.5x on $6.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 154x on $273.0M net income, trailing 12 months to June 30, 2026

Price / Book 2.9x on $14.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VTR SEC filings page.

Ventas, Inc. (VTR) reported $5.8B in revenue for fiscal year 2025, up 18.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VTR FY2025 2026-10-03

Operating cash generation is improving, but reinvestment and distributions consume more cash than operations produce.

In FY2025, operating cash flow of $1.6B was more than six times net income of $262M, a gap consistent with heavy noncash depreciation rather than weak cash generation. Yet free cash flow was -$1.3B, showing that reinvestment absorbed more cash than operations generated.

Leverage eased from 1.4x to 1.0x over the latest two years even as total assets expanded, indicating a less debt-dependent funding mix rather than a smaller business.

FY2025 dividends of $860M exceeded net income of $262M, so distributions were not funded solely by that year's accounting profit. Shares outstanding rose from 402.5M to 475.0M, meaning total-earnings improvement does not translate one-for-one into per-share economics.

Financial Health Signals

Financial Health Score 33/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ventas, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Ventas, Inc. scores 50/100 on it among other REITs.

FFO Growth

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Ventas, Inc. scores 61/100 on it among other REITs.

Leverage

Not available for Ventas, Inc., and counted as zero in the overall score.

Interest Cov.

Not available for Ventas, Inc., and counted as zero in the overall score.

AFFO Margin

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Ventas, Inc. scores 14/100 on it among other REITs.

Dividend Cov.

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Ventas, Inc. scores 71/100 on it among other REITs.

Piotroski F-Score Partial

6/7

Ventas, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

6.30x

For every $1 of reported earnings, Ventas, Inc. generates $6.30 in operating cash flow ($1.6B OCF vs $261.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.7B

YoY+21.7%

QoQ+4.4%

5Y CAGR+13.5%

10Y CAGR+7.4%

Ventas, Inc. generated $1.7B in revenue in Q2 2026. This represents an increase of 21.7% from the same quarter a year earlier. Against the prior quarter it is up 4.4%.

Net Income

$72.2M

YoY+1.1%

QoQ+22.3%

5Y CAGR-3.9%

10Y CAGR-6.6%

Ventas, Inc. reported $72.2M in net income in Q2 2026. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is up 22.3%.

EPS (Diluted)

$0.14

YoY-6.7%

QoQ+27.3%

5Y CAGR-9.5%

10Y CAGR-10.4%

Ventas, Inc. earned $0.14 per diluted share (EPS) in Q2 2026. This represents a decrease of 6.7% from the same quarter a year earlier. Against the prior quarter it is up 27.3%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$199.0M

YoY-67.6%

QoQ+8.4%

5Y CAGR-3.2%

10Y CAGR+13.3%

Ventas, Inc. held $199.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.52

YoY+8.3%

QoQ0.0%

Ventas, Inc. paid $0.52 per share in dividends in Q2 2026. This represents an increase of 8.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

513M

YoY+12.9%

QoQ+5.5%

5Y CAGR+6.2%

10Y CAGR+3.9%

Ventas, Inc. had 513M shares outstanding in Q2 2026. This represents an increase of 12.9% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

4.2%

YoY-0.9pp

QoQ+0.6pp

5Y change-5.4pp

10Y change-12.7pp

Ventas, Inc.'s net profit margin was 4.2% in Q2 2026, showing the share of revenue converted to profit. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Return on Equity

0.5%

YoY-0.1pp

QoQ0.0pp

5Y change-0.4pp

10Y change-1.0pp

Ventas, Inc.'s ROE was 0.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.1 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

VTR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VTR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$6.4B	$5.8B+18.5%	$4.9B+9.5%	$4.5B+8.9%	$4.1B+7.9%	$3.8B+0.9%	$3.8B-2.0%	$3.9B+3.4%	$3.7B+4.8%	$3.6B+3.8%	$3.4B+4.8%	$3.3B+18.4%	$2.8B+10.3%	$2.5B+1.9%	$2.5B+42.6%	$1.7B
SG&A Expenses	$191.1M	$177.4M+8.8%	$163.0M+9.5%	$148.9M+2.8%	$144.9M+11.6%	$129.8M-0.3%	$130.2M-18.0%	$158.7M+8.7%	$146.0M+7.7%	$135.5M+6.8%	$126.9M-0.9%	$128.0M+5.2%	$121.7M+5.8%	$115.1M+16.8%	$98.5M+32.2%	$74.5M
Interest Expense	$628.8M	$612.2M+1.6%	$602.8M+5.0%	$574.1M+22.8%	$467.6M+6.2%	$440.1M-6.3%	$469.5M+4.0%	$451.7M+2.1%	$442.5M-1.3%	$448.2M+6.8%	$419.7M+14.3%	$367.1M+25.7%	$292.1M+17.3%	$249.0M-13.8%	$288.7M+29.0%	$223.8M
Income Tax	-$49.0M	-$14.2M+62.5%	-$37.8M-296.0%	-$9.5M+43.6%	-$16.9M-450.7%	$4.8M+105.0%	-$96.5M-71.4%	-$56.3M-40.9%	-$40.0M+33.2%	-$59.8M-90.8%	-$31.3M+20.2%	-$39.3M-349.9%	-$8.7M+26.2%	-$11.8M-88.3%	-$6.3M+79.5%	-$30.7M
Net Income	$273.0M	$261.5M+196.0%	$88.4M+391.6%	-$30.3M+26.0%	-$40.9M-172.4%	$56.6M-87.2%	$441.2M+0.4%	$439.3M+5.6%	$416.0M-69.4%	$1.4B+108.9%	$651.5M+55.4%	$419.2M-12.1%	$477.0M+4.9%	$454.7M+25.7%	$361.8M-0.4%	$363.3M
EPS (Basic)	N/A	$0.55+175.0%	$0.20+300.0%	-$0.10+16.7%	-$0.12-192.3%	$0.13-89.0%	$1.180.0%	$1.18+2.6%	$1.15-69.9%	$3.82+103.2%	$1.88+49.2%	$1.26-22.2%	$1.62+4.5%	$1.55+25.0%	$1.24-22.5%	$1.60
EPS (Diluted)	$0.53	$0.54+184.2%	$0.19	-$0.10+16.7%	-$0.12-192.3%	$0.13-88.9%	$1.170.0%	$1.17+2.6%	$1.14-69.8%	$3.78+103.2%	$1.86+48.8%	$1.25-21.9%	$1.60+3.9%	$1.54+25.2%	$1.23-22.2%	$1.58
Diluted Shares (Avg)	N/A	463M+11.1%	416M	406M+0.5%	403M+4.4%	386M+2.6%	377M+1.8%	370M+2.9%	359M+0.2%	359M+2.9%	348M+4.3%	334M+12.6%	297M+0.5%	295M+0.2%	294M+27.6%	231M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.7B+21.7%	$1.7B+22.0%	$1.6B+21.7%	$1.5B+20.4%	$1.4B+18.3%	$1.4B+13.2%	$1.3B+10.5%	$1.2B+7.5%
SG&A Expenses	$47.0M+9.6%	$62.7M+18.1%	$41.0M-1.0%	$40.4M+15.1%	$42.9M+13.6%	$53.1M+9.1%	$41.4M+13.9%	$35.1M+5.4%
Interest Expense	$160.0M+6.5%	$156.1M+4.5%	$154.5M+0.8%	$158.1M+5.1%	$150.3M+0.7%	$149.4M-0.4%	$153.2M-1.1%	$150.4M+1.7%
Income Tax	-$25.6M-761.3%	-$15.9M-51.0%	-$1.1M+97.5%	-$6.3M-311.4%	$3.9M-50.1%	-$10.6M-251.4%	-$45.5M-1069.3%	$3.0M+280.6%
Net Income	$72.2M+1.1%	$59.0M+22.1%	$73.0M+24.3%	$68.7M+227.2%	$71.5M+237.6%	$48.4M+485.6%	$58.7M+169.3%	$21.0M+130.2%
EPS (Basic)	$0.14-6.7%	$0.12+9.1%	$0.15+7.1%	$0.14+180.0%	$0.15+200.0%	$0.11+375.0%	$0.14+163.6%	$0.05+127.8%
EPS (Diluted)	$0.14-6.7%	$0.11+10.0%	$0.14+7.7%	$0.14+180.0%	$0.15+200.0%	$0.10	$0.13+159.1%	$0.05+127.8%
Diluted Shares (Avg)	498M+8.4%	487M+9.0%	N/A	463M+10.5%	459M+11.5%	446M	N/A	419M+3.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

VTR Balance Sheet

VTR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$27.6B+5.4%	$26.2B+5.9%	$24.7B+2.3%	$24.2B-2.3%	$24.7B+3.3%	$23.9B-3.1%	$24.7B+9.3%	$22.6B-5.7%	$24.0B+3.4%	$23.2B+4.1%	$22.3B+5.2%	$21.2B+7.3%	$19.7B+4.0%	$19.0B+9.9%	$17.3B
Cash & Equivalents	$741.1M-17.5%	$897.9M+76.5%	$508.8M+315.1%	$122.6M-18.1%	$149.7M-63.8%	$413.3M+288.6%	$106.4M+47.2%	$72.3M-11.2%	$81.4M-71.6%	$286.7M+440.7%	$53.0M-4.2%	$55.3M-41.6%	$94.8M+39.6%	$67.9M+48.2%	$45.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.0B+0.1%	$1.0B0.0%	$1.0B+0.1%	$1.0B-0.2%	$1.0B-0.5%	$1.1B0.0%	$1.1B+0.1%	$1.1B+1.5%	$1.0B+0.1%	$1.0B-1.4%	$1.0B+187.8%	$364.0M	N/A	$490.5M+9.4%	$448.4M
Total Liabilities	$14.6B-2.8%	$15.0B+1.1%	$14.9B+8.8%	$13.7B+1.3%	$13.5B+0.6%	$13.4B-3.3%	$13.9B+14.4%	$12.1B-5.7%	$12.9B+3.4%	$12.4B0.0%	$12.4B+1.6%	$12.2B+14.7%	$10.7B+9.8%	$9.7B+24.4%	$7.8B
Long-Term Debt	$13.0B-3.8%	$13.5B+0.2%	$13.5B+9.7%	$12.3B+2.2%	$12.0B+1.1%	$11.9B-2.2%	$12.2B+13.3%	$10.7B-4.8%	$11.3B+1.3%	$11.1B-0.7%	$11.2B+3.3%	$10.8B+15.8%	$9.4B+11.3%	$8.4B+30.9%	$6.4B
Total Equity	$12.5B+16.3%	$10.8B+13.5%	$9.5B-6.5%	$10.2B-6.5%	$10.9B+6.6%	$10.2B-2.5%	$10.4B+2.3%	$10.2B-6.0%	$10.9B+3.9%	$10.5B+9.4%	$9.6B+10.2%	$8.7B-1.6%	$8.8B-2.2%	$9.0B-2.8%	$9.3B
Retained Earnings	-$7.5B-9.3%	-$6.9B-10.8%	-$6.2B-14.0%	-$5.4B-16.4%	-$4.7B-16.1%	-$4.0B-9.8%	-$3.7B-25.2%	-$2.9B-30.8%	-$2.2B+9.9%	-$2.5B-17.8%	-$2.1B-38.4%	-$1.5B-35.5%	-$1.1B-44.8%	-$777.9M-88.7%	-$412.2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$29.7B+12.0%	$27.7B+6.4%	$27.6B+5.4%	$26.9B+6.2%	$26.5B+7.9%	$26.0B+5.5%	$26.2B+5.9%	$25.3B+1.5%
Cash & Equivalents	$199.0M-67.6%	$183.6M+0.7%	$741.1M-17.5%	$188.6M-82.9%	$614.2M+10.3%	$182.3M-71.2%	$897.9M+76.5%	$1.1B+154.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.0B-0.1%	$1.0B0.0%	$1.0B+0.1%	$1.0B0.0%	$1.0B+0.1%	$1.0B0.0%	$1.0B0.0%	$1.0B+0.1%
Total Liabilities	$14.4B-0.8%	$14.1B-0.4%	$14.6B-2.8%	$14.2B-6.8%	$14.6B0.0%	$14.2B-5.1%	$15.0B+1.1%	$15.2B+2.4%
Long-Term Debt	N/A	N/A	$13.0B-3.8%	N/A	N/A	N/A	$13.5B+0.2%	N/A
Total Equity	$14.6B+27.1%	$13.1B+14.4%	$12.5B+16.3%	$12.4B+26.7%	$11.5B+19.9%	$11.5B+22.0%	$10.8B+13.5%	$9.8B-0.6%
Retained Earnings	-$7.9B-9.9%	-$7.7B-9.5%	-$7.5B-9.3%	-$7.4B-9.2%	-$7.2B-9.6%	-$7.1B-10.1%	-$6.9B-10.8%	-$6.7B-13.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

VTR Cash Flow Statement

VTR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.8B	$1.6B+23.8%	$1.3B+18.7%	$1.1B0.0%	$1.1B+9.2%	$1.0B-29.2%	$1.5B+0.9%	$1.4B+4.1%	$1.4B-3.3%	$1.4B+5.5%	$1.4B-3.2%	$1.4B+11.5%	$1.3B+5.0%	$1.2B+20.3%	$992.8M+28.4%	$773.2M
Depreciation & Amortization	N/A	$1.4B+10.1%	$1.3B-10.0%	$1.4B+16.3%	$1.2B0.0%	$1.2B+7.9%	$1.1B+6.1%	$1.0B+13.7%	$919.6M+3.6%	$887.9M-1.2%	$898.9M+0.5%	$894.1M+23.3%	$725.2M+15.1%	$629.9M-11.9%	$715.0M+61.0%	$444.2M
Stock-Based Compensation	N/A	$38.7M+25.0%	$31.0M0.0%	$31.0M+0.9%	$30.7M-3.9%	$32.0M+48.8%	$21.5M-36.7%	$33.9M+13.2%	$30.0M+12.9%	$26.5M+26.6%	$21.0M+7.3%	$19.5M-6.9%	$21.0M+1.7%	$20.7M-0.6%	$20.8M+7.4%	$19.3M
Capital Expenditures	N/A	$2.9B+15.7%	$2.5B+289.5%	$649.5M-27.9%	$900.7M-50.0%	$1.8B+196.7%	$607.3M+287.5%	$156.7M+18.9%	$131.9M-0.5%	$132.6M+12.9%	$117.5M+9.3%	$107.5M+22.9%	$87.5M+7.2%	$81.6M+17.5%	$69.4M+37.6%	$50.5M
Free Cash Flow	N/A	-$1.3B-6.8%	-$1.2B-355.1%	$470.4M+114.3%	$219.5M+128.3%	-$775.9M-192.1%	$842.9M-34.2%	$1.3B+2.5%	$1.2B-3.6%	$1.3B+4.8%	$1.2B-4.2%	$1.3B+10.6%	$1.2B+4.9%	$1.1B+20.5%	$923.4M+27.8%	$722.7M
Investing Cash Flow	-$4.6B	-$2.7B-13.3%	-$2.4B-1187.3%	-$184.7M+78.5%	-$859.2M-18.7%	-$724.1M-569.3%	$154.3M+109.7%	-$1.6B-588.5%	$324.5M+134.6%	-$937.1M+22.8%	-$1.2B+49.9%	-$2.4B-17.9%	-$2.1B-60.2%	-$1.3B+40.9%	-$2.2B-117.5%	-$997.4M
Financing Cash Flow	$2.4B	$873.8M-39.5%	$1.4B+365.8%	-$543.7M-91.5%	-$283.9M+49.2%	-$558.5M+57.0%	-$1.3B-909.1%	$160.7M+109.1%	-$1.8B-162.5%	-$671.3M-793.2%	$96.8M-90.5%	$1.0B+35.0%	$758.1M+559.2%	$115.0M-90.4%	$1.2B+382.9%	$248.3M
Dividends Paid	$927.6M	$860.1M+16.2%	$740.3M+2.3%	$723.6M+0.4%	$720.3M+4.9%	$686.9M-26.0%	$928.8M-19.8%	$1.2B+2.7%	$1.1B+36.2%	$827.3M-19.3%	$1.0B+2.1%	$1.0B+14.6%	$875.6M+9.2%	$802.1M+10.1%	$728.5M+39.8%	$521.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$556.5M+17.1%	$394.6M+22.9%	$471.7M+26.2%	$378.6M+7.0%	$475.3M+41.5%	$321.1M+20.5%	$373.6M+33.9%	$353.7M+23.6%
Depreciation & Amortization	$407.7M+17.3%	$382.5M+19.0%	$352.7M+14.2%	$357.2M+17.4%	$347.7M+2.3%	$321.5M+7.1%	$308.8M-29.1%	$304.3M-17.8%
Stock-Based Compensation	N/A	$24.8M+31.9%	N/A	N/A	N/A	$18.8M+15.6%	N/A	N/A
Investing Cash Flow	-$2.0B-854.3%	-$1.1B-20.9%	-$428.7M+72.1%	-$1.2B-174.2%	-$204.4M+23.4%	-$883.7M-511.2%	-$1.5B-3449.8%	-$429.5M-3016.5%
Financing Cash Flow	$1.4B+803.1%	$90.0M+160.3%	$499.9M-47.7%	$366.1M-41.4%	$157.0M+211.9%	-$149.1M-3191.5%	$956.2M+677.9%	$624.4M+6277.8%
Dividends Paid	$253.3M+16.8%	$230.2M+15.7%	$225.7M+19.4%	$218.4M+17.3%	$217.0M+19.0%	$199.0M+8.8%	$189.0M+4.2%	$186.2M+3.1%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.

VTR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VTR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	4.5%+2.7pp	1.8%+2.5pp	-0.7%+0.3pp	-1.0%-2.5pp	1.5%-10.1pp	11.6%+0.3pp	11.3%+0.2pp	11.1%-27.0pp	38.1%+19.2pp	18.9%+6.2pp	12.8%-4.4pp	17.2%-0.9pp	18.1%+3.4pp	14.6%-6.3pp	21.0%
Return on Equity	2.1%+1.3pp	0.8%+1.1pp	-0.3%+0.1pp	-0.4%-0.9pp	0.5%-3.8pp	4.3%+0.1pp	4.2%+0.1pp	4.1%-8.5pp	12.5%+6.3pp	6.2%+1.9pp	4.4%-1.1pp	5.5%+0.4pp	5.1%+1.1pp	4.0%+0.1pp	3.9%
Return on Assets	0.9%+0.6pp	0.3%+0.5pp	-0.1%+0.1pp	-0.2%-0.4pp	0.2%-1.6pp	1.8%+0.1pp	1.8%-0.1pp	1.8%-3.8pp	5.7%+2.9pp	2.8%+0.9pp	1.9%-0.4pp	2.3%-0.1pp	2.3%+0.4pp	1.9%-0.2pp	2.1%
Debt-to-Equity	1.04-0.2x	1.26-0.2x	1.42+0.2x	1.21+0.1x	1.11-0.1x	1.170.0x	1.16+0.1x	1.050.0x	1.040.0x	1.06-0.1x	1.17-0.1x	1.25+0.2x	1.06+0.1x	0.93+0.2x	0.69
Asset Turnover	0.210.0x	0.190.0x	0.180.0x	0.170.0x	0.150.0x	0.160.0x	0.160.0x	0.170.0x	0.150.0x	0.150.0x	0.150.0x	0.130.0x	0.130.0x	0.130.0x	0.10
FCF Margin	-22.0%+2.4pp	-24.4%-34.8pp	10.5%+5.1pp	5.3%+25.6pp	-20.3%-42.5pp	22.2%-10.9pp	33.1%-0.3pp	33.4%-2.9pp	36.3%+0.3pp	35.9%-3.4pp	39.3%-2.7pp	42.0%-2.2pp	44.2%+6.8pp	37.4%-4.3pp	41.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	4.2%-0.9pp	3.6%0.0pp	4.7%+0.1pp	4.6%+2.9pp	5.0%+3.3pp	3.6%+4.6pp	4.6%+11.8pp	1.7%+7.8pp
Return on Equity	0.5%-0.1pp	0.4%0.0pp	0.6%0.0pp	0.6%+0.3pp	0.6%+0.4pp	0.4%+0.5pp	0.5%+1.4pp	0.2%+0.9pp
Return on Assets	0.2%0.0pp	0.2%0.0pp	0.3%0.0pp	0.3%+0.2pp	0.3%+0.2pp	0.2%+0.2pp	0.2%+0.6pp	0.1%+0.4pp
Debt-to-Equity	0.99-0.3x	1.07-0.2x	1.04-0.2x	1.14-0.4x	1.26-0.3x	1.24-0.4x	1.26-0.2x	1.560.0x
Asset Turnover	0.060.0x	0.060.0x	0.060.0x	0.060.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ventas, Inc. VTR	FY2025	$5.8B	$261.5M	4.5%	$42.1B	33/100
Omega Healthcare Investors Inc. OHI	FY2025	$1.2B	$609K	0.1%	$13.5B	26/100
Healthpeak Properties, Inc. DOC	FY2025	$2.8B	$71.3M	2.5%	$13.0B	34/100
Welltower Inc. WELL	FY2025	$10.8B	$936.8M	8.6%	$162.5B	42/100
CareTrust REIT, Inc CTRE	FY2025	$476.4M	$320.5M	67.3%	$8.5B	58/100
American Healthcare REIT, Inc. AHR	FY2025	$2.3B	$70.8M	3.1%	$11.1B	52/100

Where Ventas, Inc. Ranks

Frequently Asked Questions

What is Ventas, Inc.'s annual revenue?

Ventas, Inc. (VTR) reported $5.8B in total revenue for fiscal year 2025. This represents a 18.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ventas, Inc.'s revenue growing?

Ventas, Inc. (VTR) revenue grew by 18.5% year-over-year, from $4.9B to $5.8B in fiscal year 2025.

Is Ventas, Inc. profitable?

Yes, Ventas, Inc. (VTR) reported a net income of $261.5M in fiscal year 2025, with a net profit margin of 4.5%.

How much debt does Ventas, Inc. have?

As of fiscal year 2025, Ventas, Inc. (VTR) had $741.1M in cash and equivalents against $13.0B in long-term debt.

What is Ventas, Inc.'s net profit margin?

Ventas, Inc. (VTR) had a net profit margin of 4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Ventas, Inc. pay dividends?

Yes, Ventas, Inc. (VTR) paid $1.92 per share in dividends during fiscal year 2025.

What is Ventas, Inc.'s return on equity (ROE)?

Ventas, Inc. (VTR) has a return on equity of 2.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ventas, Inc.'s free cash flow?

Ventas, Inc. (VTR) recorded an outflow of $1.3B in free cash flow during fiscal year 2025. This represents a -6.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ventas, Inc.'s operating cash flow?

Ventas, Inc. (VTR) generated $1.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ventas, Inc.'s total assets?

Ventas, Inc. (VTR) had $27.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ventas, Inc.'s capital expenditures?

Ventas, Inc. (VTR) invested $2.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Ventas, Inc. have outstanding?

Ventas, Inc. (VTR) had 475M shares outstanding as of fiscal year 2025.

What is Ventas, Inc.'s debt-to-equity ratio?

Ventas, Inc. (VTR) had a debt-to-equity ratio of 1.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ventas, Inc.'s return on assets (ROA)?

Ventas, Inc. (VTR) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ventas, Inc.'s P/E ratio?

Ventas, Inc. (VTR) trades at 154x earnings, its market capitalization divided by net income of $273.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $42.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ventas, Inc.'s price-to-sales ratio?

Ventas, Inc. (VTR) trades at 6.5x sales, its market capitalization divided by revenue of $6.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $42.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ventas, Inc.'s Piotroski F-Score?

Ventas, Inc. (VTR) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ventas, Inc.'s earnings high quality?

Ventas, Inc. (VTR) has an earnings quality ratio of 6.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Ventas, Inc.?

Ventas, Inc. (VTR) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.